Characterization of the Cyclooxygenase-2 Promoter in an Adenoviral Vector and Its Application for the Mitigation of Toxicity in Suicide Gene Therapy of Gastrointestinal Cancers-Reference-Cited by-同舟云学术

Characterization of the Cyclooxygenase-2 Promoter in an Adenoviral Vector and Its Application for the Mitigation of Toxicity in Suicide Gene Therapy of Gastrointestinal Cancers

Published:2001-03 Issue:3 Volume:3 Page:385-394
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Yamamoto Masato,Alemany Ramon,Adachi Yasuo,Grizzle William E.,Curiel David T.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference46 articles.

1. Neoplasm of the large and small intestine;Levin,1996

2. Neoplasm of the stomach;Kurtz,1996

3. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA;Vile;Cancer Res.,1993

4. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors;Moolten;J. Natl. Cancer Inst.,1990

5. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors;Culver;Science,1992

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a novel oncolytic adenovirus controlled by CDX2 promoter for esophageal adenocarcinoma therapy;Journal of Gastroenterology;2024-09-04

2. Infectivity-Enhanced, Conditionally Replicative Adenovirus for COX-2-Expressing Castration-Resistant Prostate Cancer;Viruses;2023-03-31

3. Applications of tissue-specific and cancer-selective gene promoters for cancer diagnosis and therapy;Advances in Cancer Research;2023

4. Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations;Nature Communications;2022-04-19

5. Mutant myogenin promoter-controlled oncolytic adenovirus selectively kills PAX3-FOXO1-positive rhabdomyosarcoma cells;Translational Oncology;2021-02